Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
DermTech, Inc.

DermTech, Inc. (DMTK) Stock Overview

Explore DermTech, Inc.’s financial performance, market position, analyst ratings, and future outlook.

DMTK●NASDAQ
HealthcareMedical - Diagnostics & Research
$0.09
$0.01(11.32%)
U.S. Market opens in 13h 57m

DermTech, Inc. (DMTK)

Meyka AI Score

Z

Key Financials

Market Cap3.3M
P/E Ratio-0.03
EPS (TTM)$-2.65
ROE-1.06%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

DMTK Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of DermTech, Inc. (NASDAQ: DMTK) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, DermTech, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of DMTK on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.

Key metrics behind DermTech, Inc.'s NASDAQ-traded stock include a P/E ratio of -0.03 and a market capitalization of 3.3M. Combined with our AI analysis, these give both institutional and retail investors a clear view of DMTK on the NASDAQ.

Price Performance (NASDAQ: DMTK)

1-Day Change
N/A
5-Day Change
42.21%
1-Month Change
N/A
3-Month Change
-84.41%
6-Month Change
-92.71%
Year-to-Date (YTD) Change
-94.34%
1-Year Change
-97.12%
3-Year Change
-99.72%
5-Year Change
-99.55%
All-Time (Max) Change
-99.52%

Contact Information

https://www.dermtech.com
858 450 4222
11099 North Torrey Pines Road, La Jolla, CA, 92037

Company Facts

2,060 Employees
IPO DateAug 10, 2017
CountryUS

Frequently Asked Questions